Browsing by Author "Fremes, Stephen E. (7005370948)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Angiographic Outcome of Coronary Artery Bypass Grafts: The Radial Artery Database International Alliance(2020) ;Gaudino, Mario (7005592319) ;Benedetto, Umberto (13906087500) ;Fremes, Stephen E. (7005370948) ;Hare, David L. (7102709050) ;Hayward, Philip (17134822400) ;Moat, Neil (57207515942) ;Moscarelli, Marco (8979326800) ;Di Franco, Antonino (37025809400) ;Nasso, Giuseppe (6602872975) ;Peric, Miodrag (7006618529) ;Petrovic, Ivana (35563660900) ;Collins, Peter (7402501228) ;Webb, Carolyn M. (7202857888) ;Puskas, John D. (7004277063) ;Speziale, Giuseppe (7003720477) ;Yoo, Kyung Jong (7202592784) ;Girardi, Leonard N. (7005493576)Taggart, David P. (7102253640)Background: We used a large patient-level data set including 6 angiographic randomized controlled trials (RCTs) on coronary artery bypass conduits to explore incidence and determinants of coronary graft failure. Methods: Patient-level angiographic data of 6 RCTs comparing long-term outcomes of the radial artery and other conduits were joined. Primary outcome was graft occlusion at maximum follow-up. The analysis was divided as (1) left anterior descending coronary (LAD) distribution and (2) non-LAD distribution (circumflex and right coronary artery). Mixed-model multivariable Cox regression including all baseline characteristics with stratification by individual trials was used to identify predictors of graft occlusion. Results: Included were 1091 patients and 2281 grafts, consisting of 921 left internal mammary arteries, 74 right internal mammary arteries, 710 radial arteries, and 576 saphenous veins. All left internal mammary arteries were used on the LAD, the other conduits were used on the non-LAD distribution. Mean angiographic follow up was 65 ± 29 months. Occlusion rates were 2.3% for the left internal mammary arteries, 13.5% for the left internal mammary arteries, 9.4% for the right internal mammary arteries, and 17.5% for the saphenous veins. At multivariable analysis, type of conduit used, age, female sex, left ventricular ejection fraction of less than 0.50, and use of the Y graft were significantly associated with graft occlusion in the non-LAD distribution. Conclusions: Our analyses showed that failure of the left internal mammary arteries-to-LAD bypass is a very uncommon event. For the non-LAD distribution, the nonuse of radial artery, age, female sex, left ventricular ejection fraction of less than 0.50, and use of the Y graft configuration were significantly associated with midterm graft failure. © 2020 The Society of Thoracic Surgeons - Some of the metrics are blocked by yourconsent settings
Publication Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery(2019) ;Gaudino, Mario (7005592319) ;Benedetto, Umberto (13906087500) ;Fremes, Stephen E. (7005370948) ;Hare, David L. (7102709050) ;Hayward, Philip (17134822400) ;Moat, Neil (57207515942) ;Moscarelli, Marco (8979326800) ;Di Franco, Antonino (37025809400) ;Nasso, Giuseppe (6602872975) ;Peric, Miodrag (7006618529) ;Petrovic, Ivana (35563660900) ;Puskas, John D. (7004277063) ;Speziale, Giuseppe (7003720477) ;Yoo, Kyung Jong (7202592784) ;Girardi, Leonard N. (7005493576) ;Taggart, David P. (7102253640) ;Buxton, Brian (7101750784) ;Goldman, Steven (7402632090) ;Holman, William L. (7004879976) ;Habib, Robert (7102802578) ;Mao, Jialin (56498364800) ;Puskas, John D (59807574700) ;Ruttmann-Ulmer, Elfriede (25960412200) ;Schwann, Thomas A. (6603582011) ;Tatoulis, James (7003665262)Tranbaugh, Robert (6701405042)Background: Few studies have evaluated the effect of chronic calcium-channel blocker therapy (CCB) on the angiographic and clinical outcome of radial artery (RA) grafts used for coronary bypass surgery. Objectives: The purpose of this study was to evaluate if CCB influences midterm clinical and angiographic outcomes of RA grafts. Methods: Patient-level data of 6 angiographic randomized trials evaluating RA graft status at midterm follow-up were joined in this observational analysis. Cox regression and propensity score methods were used to evaluate the effect of CCB on the incidence of a composite of major adverse cardiac events (MACE) (death, myocardial infarction, and repeat revascularization) and graft occlusion. Results: The study population included 732 patients (502 on CCB). The median clinical follow-up was 60 months. The cumulative incidence of MACE at 36, 72, and 108 months was 3.7% vs. 9.3%, 13.4% vs. 17.6%, and 16.8% vs. 20.5% in the CCB and no CCB groups, respectively (log-rank p = 0.003). Protocol-driven angiographic follow-up was available in 243 patients in the CCB group and 200 in the no CCB group. The median angiographic follow-up was 55 months. The cumulative incidence of RA occlusion at 36, 72, and 108 months was 0.9% vs. 8.6%, 9.6% vs. 21.4%, and 14.3% vs. 38.9% in the CCB and no CCB groups, respectively (log-rank p < 0.001). After controlling for known confounding, CCB therapy was found to be consistently associated with a significantly lower risk of MACE (multivariate Cox hazard ratio: 0.52; 95% confidence interval: 0.31 to 0.89; p = 0.02) and RA graft occlusion (multivariate Cox hazard ratio: 0.20; 95% confidence interval: 0.08 to 0.49; p < 0.001). Conclusions: In patients with RA grafts CCB is associated with significantly better midterm clinical and angiographic RA outcomes. © 2019 American College of Cardiology Foundation
